dc.contributor.author | Cadwallader, Kara | eng |
dc.contributor.author | Jankowski, Terry Ann, 1951- | eng |
dc.date.issued | 2004 | eng |
dc.description.abstract | Rate control with long-term anticoagulation is recommended for most patients with atrial fibrillation (strength of recommendation [SOR]: A, based on randomized controlled trials [RCTs]). A rhythm-control strategy provides no survival or quality-of life benefit when compared with rate control and causes more adverse drug effects and increased hospitalizations (SOR: A, based on RCTs). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3194 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2004 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 53, no. 07 (July 2004): 581-583. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | rhythmcontrol strategy | eng |
dc.subject | drug effects | eng |
dc.subject | rate control | eng |
dc.subject.lcsh | Anticoagulants | eng |
dc.subject.lcsh | Atrial fibrillation -- Treatment | eng |
dc.title | Other than anticoagulation, what is the best therapy for those with atrial fibrillation? | eng |
dc.type | Article | eng |